VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

Cytoreductive therapy for patients with PV

Jean-Jacques Kiladjian, MD, PhD, Saint-Louis Hospital & Paris Diderot University, Paris, France, explores whether cytoreductive therapies should be prescribed for low-risk patients with polycythemia vera (PV) in addition to standard phlebotomy. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter